Human medicines: highlights of 2022
https://www.ema.europa.eu/en/news/human-medicines-highlights-2022
Welcome to the team!
The Pharmya Team is happy to welcome Manel, our new PV Expert trainee!
The European Medicines Agency (EMA) is delivering a Product Management Service (PMS) and a Substance Management Service (SMS) to support regulatory activities in the European Union (EU)
https://www.ema.europa.eu/en/human-regulatory/research-development/data-medicines-iso-idmp-standards/spor-master-data/substance-product-data-management-services?fbclid=IwAR2n_D1C_FF0oRphglmchOODcHaeMU-9JxVlSRp4FrBuuBLdSePYAl-Utd8
Drug clinical trials: the CTIS portal becomes the sole entry point for new requests as of the 31st of January 2023
https://ansm.sante.fr/actualites/essais-cliniques-medicaments-le-portail-ctis-devient-lunique-point-dentree-pour-les-nouvelles-demandes-au-31-janvier-2023?fbclid=IwAR1Iw2CrNskojkz-AQ-WTsgdS4DE4LkvlQShsXdm2jXeFdrvQ_RwUGvWJoc
Shortages of antibiotics affecting the EU are a public health concern
https://www.ema.europa.eu/en/news/joint-statement-executive-steering-group-shortages-safety-medicinal-products-mssg-shortages